Literature DB >> 11403211

Adrenomedullin suppresses fMLP-induced upregulation of CD11b of human neutrophils.

Y Saito1, C Nakagawa, H Uchida, F Sasaki, H Sakakibara.   

Abstract

In this study we investigated the effect of adrenomedullin (AM) on fMLP-mediated activation of human neutrophils. AM partially, but significantly, suppressed fMLP-induced upregulation of CD11b expression. The inhibitory effects of AM upon fMLP-induced upregulation of CD11b expression were completely blocked by CGRP [8-37], a CGRP receptor antagonist. AM significantly increased cAMP content in neutrophils and SQ-22,536, an adenylate cyclase inhibitor, and KT-5720, a PKA inhibitor, significantly blocked the inhibitory effects of AM upon fMLP-induced upregulation of CD11b expression. This study indicates that binding of AM to the CGRP receptor suppresses fMLP-induced upregulation of CD11b expression of human neutrophils by increasing intracellular cAMP levels. AM may play an important role in the regulation of inflammatory processes, especially in the binding of neutrophils to vascular endothelial cells and subsequent neutrophil emigration evident in acute pulmonary inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403211     DOI: 10.1023/a:1011092532100

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  21 in total

1.  Adrenomedullin production is correlated with differentiation in human leukemia cell lines and peripheral blood monocytes.

Authors:  A Kubo; N Minamino; Y Isumi; K Kangawa; K Dohi; H Matsuo
Journal:  FEBS Lett       Date:  1998-04-17       Impact factor: 4.124

Review 2.  Bronchoalveolar lavage in patients with the adult respiratory distress syndrome.

Authors:  S Idell; A B Cohen
Journal:  Clin Chest Med       Date:  1985-09       Impact factor: 2.878

3.  Neutrophil function in a rat model of endotoxin-induced lung injury.

Authors:  R K Simons; R V Maier; E S Lennard
Journal:  Arch Surg       Date:  1987-02

4.  Production of adrenomedullin in human vascular endothelial cells.

Authors:  T Ishihara; J Kato; K Kitamura; F Katoh; S Fujimoto; K Kangawa; T Eto
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

5.  Differential evaluation of bronchoalveolar lavage cells and leukotrienes in unilateral acute lung injury and ARDS patients.

Authors:  M Antonelli; L Lenti; M Bufi; R A De Blasi; G Vivino; G Conti; P Pelaia; A Zicari; G Pontieri; A Gasparetto
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

6.  Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells.

Authors:  S Sugo; N Minamino; H Shoji; K Kangawa; K Kitamura; T Eto; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

7.  Adrenomedullin mediates vasodilation via CGRP1 receptors.

Authors:  M Entzeroth; H N Doods; H A Wieland; W Wienen
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

8.  Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis.

Authors:  Y Hirata; C Mitaka; K Sato; T Nagura; Y Tsunoda; K Amaha; F Marumo
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

9.  Receptors for adrenomedullin in human vascular endothelial cells.

Authors:  J Kato; K Kitamura; K Kangawa; T Eto
Journal:  Eur J Pharmacol       Date:  1995-04-28       Impact factor: 4.432

10.  Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat.

Authors:  H Shoji; N Minamino; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1995-10-13       Impact factor: 3.575

View more
  8 in total

1.  Peripheral administration of human adrenomedullin and its binding protein attenuates stroke-induced apoptosis and brain injury in rats.

Authors:  Wayne W Chaung; Rongqian Wu; Youxin Ji; Zhimin Wang; Weifeng Dong; Cletus Cheyuo; Lei Qi; Xiaoling Qiang; Haichao Wang; Ping Wang
Journal:  Mol Med       Date:  2011-06-17       Impact factor: 6.354

2.  Attenuation of hyperoxia-induced lung injury in rats by adrenomedullin.

Authors:  Wei Tao; Yu-Sheng Shu; Qian-Bing Miao; Ya-Bing Zhu
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils.

Authors:  Guillaume Monneret; Maud Arpin; Fabienne Venet; Karim Maghni; Anne-Lise Debard; Alexandre Pachot; Alain Lepape; Jacques Bienvenu
Journal:  Intensive Care Med       Date:  2003-04-24       Impact factor: 17.440

4.  Human adrenomedullin and its binding protein ameliorate sepsis-induced organ injury and mortality in jaundiced rats.

Authors:  Juntao Yang; Rongqian Wu; Mian Zhou; Ping Wang
Journal:  Peptides       Date:  2010-02-02       Impact factor: 3.750

5.  Human adrenomedullin and its binding protein attenuate tissue injury and inflammation following hepatic ischemia reperfusion in rabbits.

Authors:  Asha Jacob; Zhimin Wang; Hao Ting Yen; Ping Wang
Journal:  Heliyon       Date:  2021-08-20

6.  Human adrenomedullin and its binding protein attenuate organ injury and reduce mortality after hepatic ischemia-reperfusion.

Authors:  Juntao Yang; Rongqian Wu; Xiaoling Qiang; Mian Zhou; Weifeng Dong; Youxin Ji; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

Review 7.  Current trends in inflammatory and immunomodulatory mediators in sepsis.

Authors:  Monowar Aziz; Asha Jacob; Weng-Lang Yang; Akihisa Matsuda; Ping Wang
Journal:  J Leukoc Biol       Date:  2012-11-07       Impact factor: 4.962

8.  Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin.

Authors:  Cristina Almengló; Xiaoran Fu; María Teresa Flores-Arias; Ángel L Fernández; Juan E Viñuela; José M Martínez-Cereijo; Darío Durán; Moisés Rodríguez-Mañero; José R González-Juanatey; Sonia Eiras
Journal:  J Cell Mol Med       Date:  2022-07-11       Impact factor: 5.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.